Clinical Trials Logo
  1. Home
  2. Autonomic Nervous System
  3. NCT04896424

Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation

Catheter Ablation Clinical Trial

Official title:
Does Vagal Response Indicate Cardiac Autonomic Modulation and Improve the Therapeutic Effect of Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation? Insides From Cryoballoon Ablation

Clinical Trial Summary

The investigators sought to evaluate the incidence and influence of vagal response observed during cryoballoon-based pulmonary vein isolation on the cardiac autonomic nervous system (CANS) and ablation outcomes in paroxysmal atrial fibrillation cohort. 296 patients were treated with a 28-mm second-generation cryoballoon (Arctic Front Advance, Medtronic). Preprocedural pulmonary veins anatomy and their ostial dimensions were acquired with a computed tomography. 74 patients without structural heart disease and with no concomitant diseases were chosen for a detailed CANS assessment with heart rate variability analysis. All patients were screened over a 2-year post-ablation period.

Clinical Trial Description

An interplay between left atrial (LA) ganglionated plexi (GP), a part of the intrinsic cardiac autonomic nervous system (CANS), and pulmonary veins (PVs) is considered to be an important mechanism related with the initiation and maintenance of atrial fibrillation (AF). Therefore additional GP ablation has been reported with better ablation outcomes when added to RF-based PV isolation (PVI). A cryoballoon ablation (CBA) is an anatomically based approach which allows PVI that is highly safe and efficacious. The extension of the scar created by the cryoballoon frequently extends beyond the PV orifice in the acute and chronic post-ablation phase creating a set of lesions that are near the LA-GP area and inadvertent damage. A marked vagal response (VR) observed during CBA is considered a marker for the CANS modification. However, changes in the autonomic tone were independently noted from the presence of VR in several studies. Moreover, it is not clear if these changes are transient or long-lasting, and it has been shown that the presence of VR increases ablation success although with conflicting results. In previous studies assessing the influence of CBA on the autonomic balance, CANS modulation was appraised with different surrogates, a small number of individuals were usually recruited and both paroxysmal and persistent AF populations were included. Therefore, the investigators sought to evaluate the incidence of VR observed during CBA-based PVI, its impact on CANS assessed with widely accepted heart rate variability (HRV) analysis, and in relation to ablation outcomes in a large paroxysmal AF (PAF) cohort. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04896424
Study type Interventional
Source Pomeranian Medical University Szczecin
Contact
Status Completed
Phase N/A
Start date November 1, 2015
Completion date December 31, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT03593486 - Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation N/A
Terminated NCT01546207 - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia N/A
Active, not recruiting NCT06124690 - Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas N/A
Recruiting NCT05251545 - Randomized Trial: High Power Short Duration Versus Ablation Index N/A
Not yet recruiting NCT04780438 - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Early Phase 1
Active, not recruiting NCT03695484 - Registry Evaluating AF Ablation Techniques
Recruiting NCT05777850 - High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter N/A
Not yet recruiting NCT05565183 - Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation. N/A
Recruiting NCT06160076 - Inflammatory Response Following " Pulsed Field Ablation " vs. Radiofrequency Ablation-2
Not yet recruiting NCT05575544 - Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation N/A
Recruiting NCT04678258 - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation N/A
Active, not recruiting NCT01630031 - Contact Force Sensing and Pulmonary Vein Isolation N/A
Completed NCT04906720 - Post-Ablation Pericarditis Reduction Study Phase 2
Not yet recruiting NCT05273645 - PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study
Completed NCT03140631 - Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Phase 4
Active, not recruiting NCT03514693 - Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation N/A
Recruiting NCT03832959 - Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study. N/A
Not yet recruiting NCT05716581 - Prognostic Factors for Ablation of Atrial Fibrillation
Active, not recruiting NCT04405258 - Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial Phase 4
Completed NCT03340922 - MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation Phase 4